Lenalidomide is to be approved as an alternative to thalidomide as a first-line treatment for multiple myeloma on the NHS, it was announced last week.
Regulators at the National Institute for Health and Care Excellence (NICE) say it may spare some...
5 years ago
In our latest Meet the Member feature, we spoke with Huw Rowswell, a Nurse Consultant in Thrombosis at University Hospitals Plymouth NHS Trust. In April Huw's research work was recognised as he won the NIHR / BSH Researcher of the Year award at o...
5 years ago
